Cigna Group (NYSE:CI) Rating Lowered to “Hold” at Wall Street Zen

Cigna Group (NYSE:CIGet Free Report) was downgraded by Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued on Saturday.

A number of other brokerages have also recently commented on CI. Morgan Stanley reaffirmed an “overweight” rating and issued a $355.00 price target on shares of Cigna Group in a research note on Friday, October 31st. Sanford C. Bernstein decreased their target price on shares of Cigna Group from $346.00 to $294.00 and set a “market perform” rating on the stock in a research note on Wednesday, November 12th. Truist Financial lowered their price target on shares of Cigna Group from $375.00 to $310.00 in a report on Friday, October 31st. Raymond James Financial restated a “strong-buy” rating on shares of Cigna Group in a research report on Monday, November 3rd. Finally, Guggenheim reaffirmed a “buy” rating and set a $318.00 price objective on shares of Cigna Group in a research note on Tuesday, December 2nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $331.83.

Read Our Latest Stock Analysis on CI

Cigna Group Stock Performance

Cigna Group stock opened at $272.11 on Friday. The firm has a fifty day simple moving average of $277.41 and a two-hundred day simple moving average of $292.81. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.74. Cigna Group has a twelve month low of $239.51 and a twelve month high of $350.00. The company has a market capitalization of $72.69 billion, a PE ratio of 12.00, a P/E/G ratio of 1.00 and a beta of 0.26.

Cigna Group (NYSE:CIGet Free Report) last announced its quarterly earnings data on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.64 by $0.19. The firm had revenue of $69.57 billion for the quarter, compared to analysts’ expectations of $66.40 billion. Cigna Group had a return on equity of 18.80% and a net margin of 2.29%.The company’s revenue for the quarter was up 9.5% compared to the same quarter last year. During the same period last year, the firm earned $7.51 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Research analysts expect that Cigna Group will post 29.77 EPS for the current year.

Insider Activity

In other Cigna Group news, CEO David Cordani acquired 4,134 shares of the company’s stock in a transaction that occurred on Monday, November 3rd. The shares were acquired at an average price of $241.88 per share, with a total value of $999,931.92. Following the completion of the purchase, the chief executive officer directly owned 157,935 shares of the company’s stock, valued at approximately $38,201,317.80. The trade was a 2.69% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Brian C. Evanko sold 5,368 shares of the firm’s stock in a transaction that occurred on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the transaction, the insider directly owned 51,182 shares of the company’s stock, valued at $15,354,600. This represents a 9.49% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.70% of the company’s stock.

Institutional Investors Weigh In On Cigna Group

Several hedge funds have recently added to or reduced their stakes in the stock. Wilsey Asset Management Inc. grew its stake in Cigna Group by 2.9% in the second quarter. Wilsey Asset Management Inc. now owns 101,936 shares of the health services provider’s stock valued at $33,698,000 after purchasing an additional 2,847 shares during the last quarter. SCS Capital Management LLC boosted its holdings in shares of Cigna Group by 39.1% in the 2nd quarter. SCS Capital Management LLC now owns 30,633 shares of the health services provider’s stock valued at $10,127,000 after buying an additional 8,609 shares in the last quarter. Retirement Systems of Alabama grew its position in shares of Cigna Group by 3.9% in the 2nd quarter. Retirement Systems of Alabama now owns 165,487 shares of the health services provider’s stock worth $54,707,000 after buying an additional 6,155 shares during the last quarter. Modern Wealth Management LLC raised its stake in shares of Cigna Group by 91.3% during the 1st quarter. Modern Wealth Management LLC now owns 3,130 shares of the health services provider’s stock worth $1,030,000 after acquiring an additional 1,494 shares in the last quarter. Finally, Janney Montgomery Scott LLC boosted its stake in Cigna Group by 3.9% in the second quarter. Janney Montgomery Scott LLC now owns 35,943 shares of the health services provider’s stock valued at $11,882,000 after acquiring an additional 1,357 shares in the last quarter. 86.99% of the stock is owned by institutional investors.

Cigna Group Company Profile

(Get Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Recommended Stories

Analyst Recommendations for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.